drugset / Trial / NCT02733393

Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy

NCT02733393

Phase 1 Completed 2 enrolled NYU Langone Health
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients. The primary outcome variable will be reduction of shoulder pain.

Timeline

Start
2015-09
Primary completion
2017-09-05
Completion
2017-09-05

Drugs

EvaluationDrugModalityDoseRoute
Background Lidocaine Other / unclassified 0.1 ml
Background Lidocaine Other / unclassified 4 %